drugset / Trial / NCT02398357

The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis

NCT02398357

Phase 4 Unknown 96 enrolled Shanghai Zhongshan Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

To determine the effect and safety of anticoagulation after endoscopic therapy in cirrhotic patients with portal vein thrombosis and to explore whether it can decrease the short-term rebleeding rate.

Timeline

Start
2015-03
Primary completion
2017-08
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Nadroparin Calcium Other / unclassified 4100 iu Subcutaneous
Subject Warfarin Small molecule 2.5 mg